Citation: | ZHANG Yan, JIANG Zhenzhou, ZHANG Luyong. Ameliorative effect of psoralen on acute liver injury induced by carbon tetrachloride in mice[J]. Journal of China Pharmaceutical University, 2021, 52(5): 596-602. DOI: 10.11665/j.issn.1000-5048.20210512 |
[1] |
.Am J Chin Med,2016,44(1):35-60.
|
[2] |
Lu YQ,Zhang X,Wang JJ,et al.Research progress on chemical constituents and pharmacological actions of Psoralea Fructus[J].Chin J Exp Tradit Med Form(中国实验方剂学杂志),2019,25(3):180-189.
|
[3] |
Wang LY,Su QB,Bi HE,et al.In vivo absorption of psoralen using improved rat intestinal perfusion model[J].J China Pharm Univ(中国药科大学学报),2007,38(3) :265-268.
|
[4] |
Lei Z,Ma WD,Yu KQ,et al.Pharmacokinetics research advances of coumarin compounds in vivo[J].Chin Pharm(中国药业),2016,25(23):5-8.
|
[5] |
Liu XD,Wen WJ,Zhao ZJ. Protective effect of total flavonoids from Lithocarpus polystachyus rehd on CCl4-induced acute liver injury in mice[J].Her Med(医药导报),2020,39(12):1626-1630.
|
[6] |
Niu SL,Zhang XN,Wu ZL,et al. Hepatoprotective effect of total flavones of Artemisia capillaris thunb on acute hepatic injury in rats[J].Her Med(医药导报),2016,35(3):246-248.
|
[7] |
Jin Y,Xu F,Lu Y. Discussion and suggestion on the method of histopathologic diagnosis of rat and mouse liver acute injury induced by carbon tetrachloride[J].Chin J New Drugs(中国新药杂志),2014,23(19):2224-2227.
|
[8] |
Correia MA,Kwon D.Why Hepatic CYP2E1-elevation by itself is insufficient for inciting NAFLD/NASH:inferences from two genetic knockout mouse models[J].Biology,2020,9(12) :419.
|
[9] |
Zhou L,Tang J,Yang X,et al.Five constituents in Psoralea corylifolia L.attenuate palmitic acid-induced hepatocyte injury via inhibiting the protein kinase C-α/nicotinamide-adenine dinucleotide phosphate oxidase pathway[J].Front Pharmacol,2019,10 :1589.
|
[10] |
Wang XM,Peng PK,Pan ZQ,et al. Psoralen inhibits malignant proliferation and induces apoptosis through triggering endoplasmic reticulum stress in human SMMC7721 hepatoma cells[J].Biol Res,2019,52(1):34.
|
[11] |
Li DG,Wang JH,Gao SF,et al.Effects of psoralen on the proliferation and oxidative stress of hepatic stellate cell(HSC-T6) and the secretion of collagen Ⅰ[J].Nat Prod Res Dev(天然产物研究与开发),2011,23(1) :35-38.
|
[12] |
Yang K,Gao R,Ma YZ,et al.Research progress on mechanism of pharmacological effects and hepatotoxicity of psoralen[J].Chin Tradit Herbal Drugs(中草药),2021,52(1) :289-298.
|
[13] |
Xu B,Tian J,Ma N,et al. Progress in animal models of liver injury[J].China Mod Med(中国当代医药),2019,26(14):38-40,44.
|
[14] |
Peng XY,Dai CS,Liu QW,et al. Curcumin attenuates on carbon tetrachloride-induced acute liver injury in mice via modulation of the Nrf2/HO-1 and TGF-β1/Smad3 pathway[J].Molecules,2018,23(1):215.
|
[15] |
Ta?eb D,Malicet C,Garcia S,et al. Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity[J].Hepatology,2005,42(1):176-182.
|
[16] |
Liang PS,Zhou W,Jiang ZZ,et al. Mechanism of psoralen in aggravating hepatotoxicity induced by CCl4 by delaying liver regeneration[J].China J Chin Mater Med(中国中药杂志),2020,45(12):2916-2923.
|
[17] |
Guo FC,Zhuang XY,Han MY,et al. Polysaccharides from Enteromorpha prolifera protect against carbon tetrachloride-induced acute liver injury in mice via activation of Nrf2/HO-1 signaling,and suppression of oxidative stress,inflammation and apoptosis[J].Food Funct,2020,11(5):4485-4498.
|
[18] |
Zeng BY,Su MH,Chen QX,et al. Protective effect of a polysaccharide from Anoectochilus roxburghii against carbon tetrachloride-induced acute liver injury in mice[J].J Ethnopharmacol,2017,200:124-135.
|
[19] |
Feng L,Wang L,Jiang XH. Pharmacokinetics,tissue distribution and excretion of coumarin components from Psoralea corylifolia L. in rats[J]. Arch Pharm Res,2010,33(2):225-230.
|
[20] |
Wang X,Lou YJ,Wang MX,et al. Furocoumarins affect hepatic cytochrome P450 and renal organic ion transporters in mice[J].Toxicol Lett,2012,209(1):67-77.
|
[21] |
Yang CS,Chhabra SK,Hong JY,et al. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide(DAS) and related compounds from garlic[J].J Nutr,2001,131(3s):1041S-1045S.
|
[22] |
Brady JF,Ishizaki H,Fukuto JM,et al. Inhibition of cytochrome P-450 2E1 by diallyl sulfide and its metabolites[J].Chem Res Toxicol,1991,4(6):642-647.
|
[1] | XU Linhao, LIU Xinze, LIU Wei, XIANG Ping, HANG Taijun, YANG Shuo, YAN Hui. Application of zebrafish model in the metabolism of new psychoactive substances[J]. Journal of China Pharmaceutical University, 2022, 53(5): 606-612. DOI: 10.11665/j.issn.1000-5048.20220511 |
[2] | CHENG Liyuan, LIU Wei, GUO Xiaoyan, GE Xiaoai, WANG Dingding, WANG Tao. Effects and mechanism of zidovudine on glucolipid metabolic balance in mice[J]. Journal of China Pharmaceutical University, 2022, 53(3): 340-347. DOI: 10.11665/j.issn.1000-5048.20220312 |
[3] | WANG Jingqi, WANG Ye, ZHANG Yi, LIANG Juncheng, DENG Yanping, HANG Taijun, SONG Min. Metabolomic study on clinical staging of methamphetamine detoxification by LC-QTOF-MS[J]. Journal of China Pharmaceutical University, 2022, 53(3): 314-322. DOI: 10.11665/j.issn.1000-5048.20220309 |
[4] | HE Mingzhe, PENG Ying, WANG Guangji, A Jiye, ZHENG Yiwen, SUN Jianguo. Mechanism of sodium salicylate-induced damage to HEI-OC1 cells based on metabonomics[J]. Journal of China Pharmaceutical University, 2021, 52(5): 566-572. DOI: 10.11665/j.issn.1000-5048.20210508 |
[5] | WU Yubing, YIN Lifang, QIN Chao. Clinical application and detection of matrix metalloproteinases in diagnosis[J]. Journal of China Pharmaceutical University, 2020, 51(5): 614-621. DOI: 10.11665/j.issn.1000-5048.20200514 |
[6] | TAO Yingjun, WU Jie, LIU Chang. Application of proteomics in diabetes and its complications[J]. Journal of China Pharmaceutical University, 2020, 51(3): 368-373. DOI: 10.11665/j.issn.1000-5048.20200315 |
[7] | YIN Kunpeng, ZHENG Hao, XIE Binxin, LI Ping, ZHANG Lei, FAN Yong, ZHU Wei, QI Lianwen. Clinical metabolomics in diagnosis and therapy of coronary artery disease[J]. Journal of China Pharmaceutical University, 2017, 48(6): 629-634. DOI: 10.11665/j.issn.1000-5048.20170601 |
[8] | ZHANG Xue, WANG Yuhao, ZHENG Yunsi, HE Hua, LIU Xiaoquan. Evaluation of the protective effect of salvianolic acid A on ischemic heart failure by a multi-target pharmacokinetic-pharmacodynamic model[J]. Journal of China Pharmaceutical University, 2016, 47(5): 587-594. DOI: 10.11665/j.issn.1000-5048.20160514 |
[9] | LI Chen, YUAN Linhua, MA Xueqin, LIU Xiaoquan, XI Tao. Variation of cardiovascular risk biomarkers in type 2 diabetes mellitus[J]. Journal of China Pharmaceutical University, 2013, 44(3): 257-262. DOI: 10.11665/j.issn.1000-5048.20130314 |
[10] | HUANG Yin, XU Fengguo, ZHANG Wei, ONG Choonnam, ZHANG Zunjian. Progress for pharmacometabolomics and its applications[J]. Journal of China Pharmaceutical University, 2013, 44(2): 105-112. DOI: 10.11665/j.issn.1000-5048.20130202 |